Gelonghui, May 15 | Kaisheng New Materials (301069.SZ) said on the investor interactive platform that currently the company purchases terephthalic anhydride products (TMA) to synthesize terephthalic anhydride acyl chloride products, and downstream is mainly used in the fields of medicine, medicine, and new materials. Currently, the sales revenue of the company's paraphthalic anhydride acyl chloride products does not account for much of the company's main business revenue, so the short-term price increase of TMA will not have an obvious impact on the company's performance.
凯盛新材(301069.SZ)：采购偏苯三酸酐产品(TMA)用于合成偏苯三酸酐酰氯产品
Kaisheng New Materials (301069.SZ): Procurement of terephthalic anhydride products (TMA) to synthesize terephthalic anhydride acyl chloride products
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.